NCT05683912已完成不适用
Aflibercept for Diabetic Macular Edema In Real-life Practice in GREece: The ADMIRE Study
University of Athens1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2019年9月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Change in best-corrected visual acuity
研究概览
简要总结
ADMIRE was a prospective, observational cohort study of patients with diabetic macular edema (DME). Efficacy was assessed by change in best-corrected visual acuity (BCVA) and central retinal thickness (CRT) from baseline to months 12, 24 and 36 after treatment with intravitreal aflibercept in treatment-naïve patients and previously treated patients. Safety was evaluated by recording any patients-reported events.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 45 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with DM, able to give written informed consent Patients with DME>320 μm, who need treatment
排除标准
- •Patients with other retinal diseases than DME Intraocular surgery within the last 6 months
结局指标
主要结局
Change in best-corrected visual acuity
时间窗: 12 months
次要结局
未报告次要终点
研究者
Irini Chatziralli
Assistant Professor in Ophthalmology
University of Athens
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or RanibizumabDiabetic Macular EdemaNCT02000102Stanford University14
Unknown
4 期
Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study)Macular Edema, DiabeticNCT02788877Pusan National University Hospital48
已完成
4 期
Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or BevacizumabMacular EdemaDiabetic RetinopathyNCT02559180Rishi Singh20
已完成
4 期
Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular EdemaRetinal DiseasesNCT02646670Instituto de Olhos de Goiania20
已完成
4 期
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)Diabetic Macular EdemaNCT04087746Minia University400